Alto Neuroscience
Clinical trials sponsored by Alto Neuroscience, explained in plain language.
-
New hope for tough depression: ALTO-207 trial launches
Symptom relief Recruiting nowThis study tests whether a new drug called ALTO-207 can reduce depression symptoms in adults whose depression has not responded to at least 2 other treatments. About 178 people will receive either ALTO-207 or a placebo for several weeks. The main goal is to see if the drug improv…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated May 26, 2026 05:05 UTC
-
New patch aims to sharpen thinking in schizophrenia
Symptom relief Recruiting nowThis study tests a new drug, ALTO-101, given through a skin patch, to see if it helps with thinking and memory problems in people with schizophrenia. About 82 adults with stable schizophrenia and cognitive issues will receive either the drug or a placebo, then switch. The main go…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC